Bio-Works Technologies AB (publ) (NGM: BIOWKS)
Sweden
· Delayed Price · Currency is SEK 0.830
0.00 (0.00%)
At close: Dec 20, 2024
Bio-Works Technologies AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Operating Revenue | 37.88 | 43.9 | 41.32 | 21.91 | 7.23 | 5.57 | Upgrade
|
| Other Revenue | - | - | - | 34.45 | - | -0 | Upgrade
|
| Revenue | 37.88 | 43.9 | 41.32 | 56.36 | 7.23 | 5.57 | Upgrade
|
| Revenue Growth (YoY) | -6.29% | 6.23% | -26.68% | 679.08% | 29.83% | -15.10% | Upgrade
|
| Cost of Revenue | 10.16 | 17.08 | 12.47 | 3.35 | 3.02 | 0.2 | Upgrade
|
| Gross Profit | 27.72 | 26.82 | 28.85 | 53.01 | 4.22 | 5.37 | Upgrade
|
| Selling, General & Admin | 65.41 | 81.63 | 74.95 | 62.5 | 49.44 | 45.68 | Upgrade
|
| Other Operating Expenses | 1.59 | 2.09 | 0.57 | 0.76 | -0.27 | - | Upgrade
|
| Operating Expenses | 67.55 | 84.33 | 75.99 | 63.97 | 49.87 | 47.5 | Upgrade
|
| Operating Income | -39.82 | -57.5 | -47.14 | -10.96 | -45.65 | -42.13 | Upgrade
|
| Interest Expense | -0.14 | -0 | -0.02 | -0.02 | -0.01 | - | Upgrade
|
| Interest & Investment Income | - | 0.88 | 0.35 | 0.07 | 0.11 | 0.12 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.89 | 1.89 | 2.12 | 1.53 | -0.21 | -0.11 | Upgrade
|
| Other Non Operating Income (Expenses) | 5.61 | - | 0 | - | -0 | - | Upgrade
|
| EBT Excluding Unusual Items | -32.46 | -54.73 | -44.7 | -9.37 | -45.76 | -42.11 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.74 | - | Upgrade
|
| Pretax Income | -35.46 | -54.73 | -44.7 | -9.37 | -45.02 | -42.11 | Upgrade
|
| Income Tax Expense | 2.06 | 2.09 | 0.26 | 3.57 | - | - | Upgrade
|
| Net Income | -37.52 | -56.82 | -44.95 | -12.94 | -45.02 | -42.11 | Upgrade
|
| Net Income to Common | -37.52 | -56.82 | -44.95 | -12.94 | -45.02 | -42.11 | Upgrade
|
| Shares Outstanding (Basic) | 40 | 36 | 35 | 31 | 30 | 30 | Upgrade
|
| Shares Outstanding (Diluted) | 40 | 36 | 35 | 31 | 30 | 30 | Upgrade
|
| Shares Change (YoY) | 13.57% | 3.16% | 12.17% | 2.60% | 0.50% | 57.08% | Upgrade
|
| EPS (Basic) | -0.94 | -1.57 | -1.28 | -0.41 | -1.48 | -1.39 | Upgrade
|
| EPS (Diluted) | -0.94 | -1.57 | -1.28 | -0.41 | -1.48 | -1.39 | Upgrade
|
| Free Cash Flow | -45.47 | -59.85 | -41 | -14.31 | -43.69 | -40.26 | Upgrade
|
| Free Cash Flow Per Share | -1.14 | -1.66 | -1.17 | -0.46 | -1.44 | -1.33 | Upgrade
|
| Gross Margin | 73.18% | 61.10% | 69.81% | 94.06% | 58.28% | 96.36% | Upgrade
|
| Operating Margin | -105.13% | -131.00% | -114.09% | -19.44% | -631.10% | -756.07% | Upgrade
|
| Profit Margin | -99.05% | -129.44% | -108.79% | -22.96% | -622.33% | -755.80% | Upgrade
|
| Free Cash Flow Margin | -120.05% | -136.34% | -99.24% | -25.39% | -603.88% | -722.56% | Upgrade
|
| EBITDA | -39.12 | -56.89 | -46.67 | -10.47 | -45.5 | -41.75 | Upgrade
|
| EBITDA Margin | -103.26% | -129.61% | -112.95% | -18.57% | - | - | Upgrade
|
| D&A For EBITDA | 0.71 | 0.61 | 0.47 | 0.49 | 0.15 | 0.38 | Upgrade
|
| EBIT | -39.82 | -57.5 | -47.14 | -10.96 | -45.65 | -42.13 | Upgrade
|
| EBIT Margin | -105.13% | -131.00% | -114.09% | -19.44% | - | - | Upgrade
|
| Revenue as Reported | 44.75 | 46.7 | 43.01 | 58.82 | 6.68 | 6.96 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.